Fewer infants than older patients in paediatric randomised controlled trials
Related Experiment Video
Updated: Jun 21, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
François Angoulvant1, Florentia Kaguelidou, Stephane Dauger
1AP-HP, Hôpital Robert Debré, Université Denis Diderot-Paris VII, Unité INSERM CIE5, 48 bd Sérurier, 75019, Paris, France. francois.angoulvant@rdb.aphp.fr
Insights
Paediatric randomised controlled trials (PRCTs) often exclude newborns and infants. This study found younger children were underrepresented in PRCTs, highlighting a need for more research in these vulnerable populations.
Area of Science:
- Clinical Research
- Paediatric Medicine
- Evidence-Based Practice
Background:
- Paediatric randomised controlled trials (PRCTs) are crucial for advancing child health.
- Concerns exist regarding the underrepresentation of the youngest age groups in clinical research.
Purpose of the Study:
- To assess the inclusion of different age groups, particularly newborns and infants, in PRCTs.
- To identify trends in paediatric trial recruitment over time.
Main Methods:
- A PubMed search was conducted for PRCTs published in leading medical journals in 2006 and 2009.
- 144 articles from 2006 and 66 from 2009 were randomly selected and analyzed for age characteristics, study design, and topic.
- The proportion of trials including newborns, infants, children, and adolescents was determined.
Main Results:
- In 2006, only 11% of PRCTs included newborns and 26% included infants.
- By 2009, trial inclusion for newborns rose to 17% and for infants to 24%.
- Respiratory diseases, infectious diseases, and mental/behavioural disorders were the most common study topics.
Conclusions:
- PRCTs in leading journals significantly underrepresent newborns and infants compared to older children.
- Increased efforts are necessary to promote research involving the youngest paediatric populations.
- Further investigation into the impact of recent regulations on paediatric drug trials is warranted.
Abstract:
To determine whether the youngest age groups are less likely to be included in paediatric randomised controlled trials (PRCTs) than older children, we conducted a PubMed search using the keyword "randomised controlled trial" and the limit "all child: 0-18 years". We retrieved 417 articles published in 2006 in 34 leading journals classified as general medical journals, paediatric medical journals, or specialist medical journals. We arbitrarily selected 144 articles, at random. For each study, we evaluated population age characteristics (central tendency, range, and dispersion), study design, sample size and topic. Of the 144 studies, only 82 were first reports of paediatric randomised controlled trials (PRCTs). Among the other studies, many were done in adults. Of the 82 PRCTs, only 11% included newborns and 26% infants; 59% included children and 39% adolescents. Using the same search strategy to retrieve PRCTs in the same journals in the last 4 months of 2009 retrieved 66 PRCTs, of which 17% included newborns, 24% infants, 61% children and 55% adolescents. The three health conditions most often reported were respiratory diseases, infectious diseases, and mental and behavioural disorders. In 34 leading journals, PRCTs were significantly less likely to include newborns and infants than older paediatric patients. Given the huge impact of PRCTs on paediatric health, additional efforts are needed to promote studies in newborns and infants, as well as studies of the impact of recent European and American regulations designed to encourage paediatric drug trials.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Related Concept Videos
Factors Affecting Drug Response: Overview
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion